+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Nagase Viita Co Ltd - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 23 Pages
  • May 2025
  • Region: Global
  • GlobalData
  • ID: 6088580
Nagase Viita Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Nagase Viita Co Ltd (Nagase Viita), a subsidiary of Nagase & Co Ltd, develops, manufactures, and sells ingredients and materials across various sectors. The company's major products include food ingredients, pharmaceutical ingredients, cosmetic ingredients, health food ingredients, functional dyes, enzymes, and phospholipids. Nagase Viita’s major brands include Treha, Hallodex, AA2G, MG-60, trehalose, maltose, and pullulan. The company caters its products to industries such as food, personal care, pharmaceuticals, agriculture, and feed. It manages manufacturing plants and research and development centers in Japan. Nagase Viita is headquartered in Okayama, Japan.

Nagase Viita Co Ltd Key Recent Developments

  • Nov 19, 2024: Nagase Viita to Launch Injectable-Grade Pharmaceutical Excipient "SUCROSE SG" in 2025

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Nagase Viita Co Ltd - Key Facts
  • Nagase Viita Co Ltd - Key Employees
  • Nagase Viita Co Ltd - Key Employee Biographies
  • Nagase Viita Co Ltd - Major Products and Services
  • Nagase Viita Co Ltd - History
  • Nagase Viita Co Ltd - Company Statement
  • Nagase Viita Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Nagase Viita Co Ltd - Business Description
  • Nagase Viita Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Nagase Viita Co Ltd - Strengths
  • Nagase Viita Co Ltd - Weaknesses
  • Nagase Viita Co Ltd - Opportunities
  • Nagase Viita Co Ltd - Threats
  • Nagase Viita Co Ltd - Key Competitors
Section 3 - Company’s Recent Developments
  • Nov 19, 2024: Nagase Viita to Launch Injectable-Grade Pharmaceutical Excipient "SUCROSE SG" in 2025
Section 4 - Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Nagase Viita Co Ltd, Key Facts
  • Nagase Viita Co Ltd, Key Employees
  • Nagase Viita Co Ltd, Key Employee Biographies
  • Nagase Viita Co Ltd, Major Products and Services
  • Nagase Viita Co Ltd, History
  • Nagase Viita Co Ltd, Other Locations
  • Nagase Viita Co Ltd, Subsidiaries
  • Nagase Viita Co Ltd, Key Competitors

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Takara Bio Inc
  • Ost Japan Group Inc
  • Noevir Holdings Co Ltd
  • Nisshin Seifun Group Inc
  • JCR Pharmaceuticals Co Ltd